Acadian Asset Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 718 shares of AMPH stock, worth $26,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

718

Holding current value

$26,207

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$36.99 - $50.09 $26,558 - $35,964	718 New	718 $34,000
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $2.33 Million - $2.6 Million	-83,303 Reduced 77.73%	23,870 $668,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $594,221 - $813,927	-21,561 Reduced 16.75%	107,173 $3.01 Million
Q2 2022 Aug 09, 2022	BUY	$29.79 - $42.29 $553,676 - $786,001	18,586 Added 16.87%	128,734 $4.48 Million
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $2 Million - $3.18 Million	87,113 Added 378.18%	110,148 $3.95 Million
Q4 2021 Feb 10, 2022	BUY	$18.14 - $23.29 $82,228 - $105,573	4,533 Added 24.5%	23,035 $534,000
Q3 2021 Nov 12, 2021	SELL	$17.83 - $21.49 $1.44 Million - $1.74 Million	-80,933 Reduced 81.39%	18,502 $350,000
Q2 2021 Aug 11, 2021	BUY	$17.11 - $20.92 $1.49 Million - $1.82 Million	86,816 Added 687.98%	99,435 $2 Million
Q1 2021 May 11, 2021	BUY	$17.21 - $20.65 $121,588 - $145,892	7,065 Added 127.21%	12,619 $231,000
Q4 2020 Feb 11, 2021	SELL	$17.76 - $21.24 $215,215 - $257,386	-12,118 Reduced 68.57%	5,554 $112,000
Q3 2020 Nov 09, 2020	SELL	$17.99 - $22.22 $197,224 - $243,597	-10,963 Reduced 38.29%	17,672 $331,000
Q2 2020 Aug 12, 2020	BUY	$14.25 - $22.46 $408,048 - $643,142	28,635 New	28,635 $642,000
Q1 2020 May 11, 2020	SELL	$12.66 - $20.08 $64,262 - $101,926	-5,076 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$17.07 - $20.64 $591,253 - $714,907	-34,637 Reduced 87.22%	5,076 $98,000
Q3 2019 Nov 07, 2019	BUY	$19.12 - $22.62 $679,008 - $803,304	35,513 Added 845.55%	39,713 $788,000
Q2 2019 Aug 08, 2019	BUY	$18.92 - $22.96 $79,464 - $96,432	4,200 New	4,200 $88,000
Q1 2019 May 09, 2019	SELL	$19.46 - $25.28 $62,310 - $80,946	-3,202 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$17.72 - $22.51 $56,739 - $72,077	3,202 New	3,202 $63,000
Q3 2018 Oct 30, 2018	SELL	$15.39 - $19.38 $305,352 - $384,518	-19,841 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$14.63 - $19.6 $2.17 Million - $2.91 Million	-148,243 Reduced 88.2%	19,841 $302,000
Q1 2018 Apr 12, 2018	SELL	$17.23 - $20.35 $54,756 - $64,672	-3,178 Reduced 1.86%	168,084 $3.15 Million
Q4 2017 Jan 18, 2018	SELL	$17.76 - $19.75 $417,981 - $464,816	-23,535 Reduced 12.08%	171,262 $3.3 Million
Q3 2017 Oct 13, 2017	BUY	$14.73 - $17.99 $2.87 Million - $3.5 Million	194,797	194,797 $3.48 Million

Others Institutions Holding AMPH

# of Institutions

279

Shares Held

36.5M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.79B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Amphastar Pharmaceuticals, Inc. Transaction History